Pharmacological analysis of the mechanisms involved in the tachycardic and vasopressor responses to the antimigraine agent, isometheptene, in pithed rats

被引:10
作者
Valdivia, LF
Centurión, D
Perusquía, M
Arulmani, U
Saxena, PR
Villalón, CM
机构
[1] CINVESTAV, IPN, Farmacobiol, Mexico City 14330, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04511, DF, Mexico
[3] Erasmus Univ, Ctr Med, Dept Pharmacol, NL-3000 DR Rotterdam, Netherlands
关键词
alpha-adrenoceptors; beta-adrenoceptors; blood pressure; heart rate; isometheptene;
D O I
10.1016/j.lfs.2003.10.033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study set out to investigate the pharmacological profile of the cardiovascular responses induced by the antimigraine agent, isometheptene, in pithed rats. For this purpose, intravenous (i.v.) administration of blocking doses of the antagonists prazosin (alpha(1); 100 mug/kg), rauwolscine (alpha(2); 300 mug/kg), the combination of prazosin (100 mug/kg) plus rauwolscine (300 mug/kg), propranolol (beta; 1000 mug/kg), ritanserin (5-HT(2); 100 mug/kg) or equivalent volumes of saline (1 ml/kg) were used. Isometheptene (0.03, 0.1, 0.3, 1 and 3 mg/kg, i.v.) produced dose-dependent increases in heart rate and diastolic blood pressure which were highly reproducible as they remained unaltered after saline. These tachycardic responses to isometheptene remained unaffected after prazosin, rauwolscine, ritanserin or the combination prazosin plus rauwolscine. but were abolished after propranolol. In contrast, the isometheptene-induced vasopressor responses were not significantly modified after the above doses of rauwolscine, ritanserin or propranolol, but were markedly blocked after prazosin or the combination of prazosin plus rauwolscine; the latter blockade did not significantly differ from that produced by prazosin alone. Interestingly, in rats pretreated intraperitoneally (i.p.) with reserpine (5 mg/kg; -24 h), isometheptene-induced tachycardic responses were abolished whereas the corresponding vasopressor responses were markedly attenuated and subsequently blocked by prazosin. It is concluded that isometheptene-induced tachycardic responses seem to involve only an indirect (tyramine-like action) mechanism mediated by beta-adrenoceptors, whilst the corresponding vasopressor responses are mediated by a predominantly indirect (tyramine-like action), as well as a minor direct (alpha(1)-adrenoceptors), sympathomimetic mechanism. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:3223 / 3234
页数:12
相关论文
共 31 条
[1]  
BROADLEY KJ, 1996, AUTONOMIC PHARM, P165
[2]  
Brodde OE, 1999, PHARMACOL REV, V51, P651
[3]   The atypical 5-HT2 receptor mediating tachycardia in pithed rats:: pharmacological correlation with the 5-HT2A receptor subtype [J].
Centurión, D ;
Ortiz, MI ;
Saxena, PR ;
Villalón, CM .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (06) :1531-1539
[4]   Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy [J].
De Vries, P ;
Villalón, CM ;
Saxena, PR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :61-74
[5]  
DELUCA A, 1988, CLIN EXP PHARMACOL P, V15, P33
[6]   ISOMETHEPTENE - NON-ERGOT DRUG IN TREATMENT OF MIGRAINE [J].
DIAMOND, S ;
MEDINA, JL .
HEADACHE, 1975, 15 (03) :211-213
[7]   TREATMENT OF MIGRAINE WITH ISOMETHEPTENE, ACETAMINOPHEN, AND DICHLORALPHENAZONE COMBINATION - DOUBLE-BLIND, CROSSOVER TRIAL [J].
DIAMOND, S .
HEADACHE, 1976, 15 (04) :282-287
[8]   Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine [J].
Freitag, FG ;
Cady, R ;
DiSerio, F ;
Elkind, A ;
Gallagher, RM ;
Goldstein, J ;
Klapper, JA ;
Rapoport, AM ;
Sadowsky, C ;
Saper, JR ;
Smith, TR .
HEADACHE, 2001, 41 (04) :391-398
[9]   INHIBITION OF PANCREATIC EXOCRINE SECRETION AND BILE ENTRY INTO THE DUODENUM BY ISOMETHEPTENE, A SYMPATHOMIMETIC AGENT [J].
GULLO, L ;
PRIORI, P ;
DANIELE, C ;
VENTRUCCI, M ;
PEZZILLI, R ;
LABO, G .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (02) :114-118
[10]  
HOFFMAN BB, 2003, PHARMACOL BASIS THER, P215